ECVT(ECVT)
ECVT
Q3 2026 EPS Estimate
$0.19
Aug 6, 2026 · Reports before open
Revenue Estimate
$237M
FY2026E EPS$0.66
FY2027E EPS$0.88
Analyst Sentiment
Wall St. Consensus
Buy6 analysts·Limited coverage
67
Score
4 Buy (67%)2 Hold (33%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
467%
Hold
233%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$9.00
-23.8%
Consensus
$10.00
-15.3%
Bull
$10.00
-15.3%
12-Month Target Range6 analysts
$9.00$10.00$10.00
Current $11.81Consensus
Current Price
$11.81
Above Consensus
$1.81
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+4.20%
EPS+33.16%
FY2028
Rev+5.89%
EPS+19.13%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $967M | $1.01B | $1.07B |
| Low | $946M | $940M | $1.06B |
| High | $987M | $1.05B | $1.08B |
| EBITDA Avg | $224M | $233M | $247M |
| Low | $219M | $218M | $245M |
| High | $229M | $244M | $249M |
| EBIT Avg | $111M | $116M | $122M |
| Low | $109M | $108M | $121M |
| High | $113M | $121M | $123M |
| Net Income Avg | $77M | $101M | $120M |
| Low | $72M | $93M | $111M |
| High | $82M | $108M | $129M |
| EPS Avg | $0.66 | $0.88 | $1.05 |
| Low | $0.62 | $0.81 | $0.96 |
| High | $0.70 | $0.93 | $1.11 |
| Analysts (Rev / EPS) | 4 / 3 | 3 / 2 | 4 / 1 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $259M | $248M | $185M | $205M | $213M | $211M | $196M | $217M |
| Low | $253M | $234M | $175M | $194M | $201M | $200M | $185M | $206M |
| High | $266M | $264M | $197M | $219M | $227M | $225M | $209M | $232M |
| EBITDA Avg | $60M | $57M | $43M | $47M | $49M | $49M | $45M | $50M |
| Low | $59M | $54M | $41M | $45M | $47M | $46M | $43M | $48M |
| High | $62M | $61M | $46M | $51M | $53M | $52M | $48M | $54M |
| EBIT Avg | $30M | $28M | $21M | $24M | $24M | $24M | $22M | $25M |
| Low | $29M | $27M | $20M | $22M | $23M | $23M | $21M | $24M |
| High | $30M | $30M | $23M | $25M | $26M | $26M | $24M | $27M |
| Net Income Avg | $24M | $18M | $13M | $23M | $25M | $21M | $17M | $28M |
| Low | $21M | $16M | $12M | $22M | $23M | $20M | $16M | $26M |
| High | $26M | $19M | $15M | $26M | $27M | $23M | $18M | $30M |
| EPS Avg | $0.21 | $0.16 | $0.12 | $0.21 | $0.22 | $0.19 | $0.15 | $0.25 |
| Low | $0.19 | $0.15 | $0.11 | $0.20 | $0.20 | $0.18 | $0.14 | $0.23 |
| High | $0.23 | $0.17 | $0.13 | $0.23 | $0.24 | $0.21 | $0.16 | $0.27 |
| Analysts (Rev / EPS) | 3 / 3 | 2 / 1 | 1 / 1 | 2 / 1 | 2 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |